Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.50
+0.20 (0.57%)
Jun 18, 2026, 1:30 PM CST
Market Cap2.73B +20.2%
Revenue (ttm)973.15M -24.5%
Net Income-160.56M
EPS-2.90
Shares Out 76.92M
PE Ration/a
Forward PEn/a
Dividend0.19 (0.54%)
Ex-Dividend DateJul 24, 2025
Volume308,735
Open35.50
Previous Close35.30
Day's Range35.05 - 35.85
52-Week Range24.20 - 44.75
Beta0.51
AnalystsHold
Price Target28.00 (-21.13%)
Earnings DateAug 12, 2026

About TPE:1762

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DMF or COS, and other API products. It also provides specialty API immunosuppressants, including mycophenolate mofetil, rapamycin, and tacrolimus; deriva... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 198
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1762
Full Company Profile

Financial Performance

Financial Statements